Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes : a Randomised Open Parallel-controlled Study
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Exenatide (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Dec 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified 30 Dec 2015 )
- 24 Mar 2016 Trial design published in the Trials.
- 31 Dec 2015 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017, according to ClinicalTrials.gov record.